Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5026 AL 5040

Nutritional interventions in community-dwelling Alzheimer patients with (risk of) undernutrition: a systematic review

Droogsma E, van Asselt D, van Steijn J, Veeger N, van Dusseldorp I, De Deyn PP.

Int Psychogeriatr. 2014 Sep;26(9):1445-1453. doi: 10.1017/S1041610214000817.

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease

Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML.

J Med Chem. 2014 Sep 11;57(17):7160-81. doi: 10.1021/jm5003952. Epub 2014 Jun 3.

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

Karran E, Hardy J.

Ann Neurol. 2014 Aug;76(2):185-205. doi: 10.1002/ana.24188. Epub 2014 Jul 2.

Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients

Koch G, Di Lorenzo F, Bonnì S, Giacobbe V, Bozzali M, Caltagirone C, Martorana A.

Neuropsychopharmacology. 2014 Oct;39(11):2654-61. doi: 10.1038/npp.2014.119. Epub 2014 May 26.

Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?

Isik AT, Soysal P, Yay A.

Am J Alzheimers Dis Other Demen. 2014 Dec;29(8):735-8. doi: 10.1177/1533317514536598. Epub 2014 May 26.

[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]

Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, García Rodríguez Jr, Hernández JR.

Rev Esp Geriatr Gerontol. 2014 Jul-Aug;49(4):165-72. doi: 10.1016/j.regg.2014.03.002. Epub 2014 May 28.

Therapeutic benefits of H₂S in Alzheimer's disease

Wei HJ, Li X, Tang XQ.

J Clin Neurosci. 2014 Oct;21(10):1665-9. doi: 10.1016/j.jocn.2014.01.006. Epub 2014 Jun 2.

An update on drug treatment options of Alzheimer's disease

Allgaier M, Allgaier C.

Front Biosci (Landmark Ed). 2014 Jun 1;19(8):1345-54. doi: 10.2741/4285.

Motor effects of radio electric asymmetric conveyer in Alzheimer's disease: results from a cross-over trial

Olazarán J, González B, Osa-Ruiz E, Felipe-Ruiz S, Boyano I, Fontani V, Castagna A, Mendoza C, Zea MA, Frades B, Rinaldi S, Martínez-Martín P.

J Alzheimers Dis. 2014;42(1):325-32. doi: 10.3233/JAD-140417.

Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?

Macdonald IR, Rockwood K, Martin E, Darvesh S.

J Alzheimers Dis. 2014;42(2):379-84. doi: 10.3233/JAD-140219.

[Antipsychotic use in the cohort PACA-Alz in patients with Alzheimer's disease and other dementia in 2010]

Bonin-Guillaume S, Martin G, Zafack J, Gentile G, Allaria-Lapierre V, Sciortino V, Thirion X, Micallef J.

Therapie. 2014 May-Jun;69(3):213-22. doi: 10.2515/therapie/2014015. Epub 2014 Jun 6.

Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014

Froestl W, Muhs A, Pfeifer A.

J Alzheimers Dis. 2014;42(1):1-68. doi: 10.3233/JAD-140402.

Brain games to slow cognitive decline in Alzheimer's disease

Anderson K, Grossberg GT.

J Am Med Dir Assoc. 2014 Aug;15(8):536-7. doi: 10.1016/j.jamda.2014.04.014. Epub 2014 Jun 7.

Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders

Farías GA, Guzmán-Martínez L, Delgado C, Maccioni RB.

J Alzheimers Dis. 2014;42(2):357-67. doi: 10.3233/JAD-132741.

Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study

Freund-Levi Y, Vedin I, Hjorth E, Basun H, Faxén Irving G, Schultzberg M, Eriksdotter M, Palmblad J, Vessby B, Wahlund LO, Cederholm T, Basu S.

J Alzheimers Dis. 2014;42(3):823-31. doi: 10.3233/JAD-132042.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias